article_metadata: Max Schlaak Patrick Schmidt Christopher Bangard Peter Kurschat Cornelia Mauch Hinrich Abken
article_metadata: 10.18632/oncotarget.437
article_metadata: Oncotarget
article_metadata: 2012 Jan;3(1):22-30.
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/22289880/
article_metadata: Antibodies, Monoclonal, Murine-Derived / therapeutic use Melanoma / therapy Neoplastic Stem Cells / immunology Skin Neoplasms / therapy
article_metadata: Antibodies, Monoclonal, Murine-Derived / therapeutic use Melanoma / therapy Neoplastic Stem Cells / immunology Skin Neoplasms / therapy Case Reports Research Support, Non-U.S. Gov't Aged Antibodies / administration & dosage Antibodies / therapeutic use Antibodies, Monoclonal, Murine-Derived / administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use Dacarbazine / administration & dosage Foot Humans Male Melanoma / pathology Molecular Targeted Therapy Neoplastic Stem Cells / drug effects Neoplastic Stem Cells / pathology Remission Induction Rituximab Skin Neoplasms / pathology Tumor Burden Antibodies Antibodies, Monoclonal, Murine-Derived Rituximab Dacarbazine
article_metadata: PMC3292889
article_metadata: 22289880
article_metadata: Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells
article_metadata: 2012